LakeShore Biopharma Co., Ltd. (LSBCF) — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2024)

¥615.0M

Net Income/Loss (FY2024)

-$13.9M

Total Assets (FY2024)

$1.4B

Total Equity (FY2024)

$1.2B

Cash Flows from Operating Activities (FY2024)

-$121.0M

Source: LakeShore Biopharma Co., Ltd. 20-F filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.